Director/PDMR Shareholding

RNS Number : 3923U
Ovoca Bio PLC
29 March 2019
 

Ovoca Bio plc

("Ovoca" or the "Company")

Grant of Share Options

 

Ovoca Bio plc (LSE: OVB; ISE:OVXA), a biopharmaceutical company focused on identifying and developing novel therapeutics targeting the large unmet needs in the treatment of female sexual dysfunction, announces that options (the "Options") over ordinary shares with a nominal value of 12.5 cent each in the share capital of the Company ("Ordinary Shares") have been awarded to certain PDMRs of the Company pursuant to the 2009 Share Option Plan, as set out below. The Options have an exercise price of 12.5 cent, a vesting period of 3 years and are subject to the satisfaction of performance conditions. In aggregate, the Company has granted options over a total of 7,100,000 Ordinary Shares to the below PDMRs and other employees of the Company. There were no other Options outstanding in the share capital of the Company prior to the grant of the Options summarised above.

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Mikhail Mogutov

 

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Executive Chairman, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of €0.125. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

2,200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Leonid Skoptsov

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Yury Radchenko

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Tim McCutcheon

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Nikolay Myasoyedov

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Chris Wiltshire

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Romulo Colindres

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Kirill Golovanov

 

 

 

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer, PDMR

 

 

 

b)

Initial Notification Amendment

 

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

 

b)

LEI

213800ST2AK5XQ1O5207

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Options over Ordinary Shares of nominal value €0.125 each

 

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

 

Grant of share options under the 2009 Share Option Scheme

 

Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.125

2,200,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (Single Transaction)

 

 

 

e)

Date of the transaction

 

27 March 2019

 

 

f)

Place of the transaction

 

Outside of a trading venue

 

 

END

Contact Information:

Ovoca Bio plc 

Kirill Golovanov (Chief Executive)

Tel +7 495 916 6029

info@ovocabio.com

 

Davy (Nominated Adviser, Euronext Growth Advisor and Broker)

John Frain / Daragh O'Reilly

Tel: +353 1 679 6363

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAXDPAFNNEFF
UK 100

Latest directors dealings